An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
Condition(s):Non-small Cell Lung CancerLast Updated:December 10, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung CancerLast Updated:December 10, 2019Completed
Condition(s):Pancreatic CancerLast Updated:October 19, 2020Completed
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:October 26, 2022Completed
Condition(s):Gastric CancerLast Updated:June 6, 2019Unknown status
Condition(s):Neuroendocrine TumorsLast Updated:September 14, 2023Not yet recruiting
Condition(s):Gastric CancerLast Updated:November 10, 2020Completed
Condition(s):Patients With Advanced or Metastatic Solid TumorsLast Updated:August 15, 2016Completed
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:December 5, 2022Recruiting
Condition(s):Advanced Biliary Tract CancerLast Updated:July 22, 2019Unknown status
Condition(s):Carcinoma; Liver Diseases; Hepatocellular CarcinomaLast Updated:February 15, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.